MacroGenics

Develops antibody-based medicines to treat cancer and autoimmune diseases.

BiotechnologyPharmaceuticals macrogenics.com ↗

Company facts

Founded
2000
Employees
350
Headquarters
United States
Type
Public
Listed
NASDAQ: MGNX